SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-053900
Filing Date
2024-05-07
Accepted
2024-05-07 06:04:53
Documents
13
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idya-20240507.htm   iXBRL 8-K 44540
2 EX-99.1 idya-ex99_1.htm EX-99.1 110258
3 GRAPHIC img107722786_0.jpg GRAPHIC 2663
  Complete submission text file 0000950170-24-053900.txt   290166

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT idya-20240507.xsd EX-101.SCH 28544
16 EXTRACTED XBRL INSTANCE DOCUMENT idya-20240507_htm.xml XML 4724
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38915 | Film No.: 24919438
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)